Mondelēz International to Report Q1 2021 Financial Results on April 27, 2021

CHICAGO, April 09, 2021 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) will release its first quarter 2021 financial results on Tuesday, April 27, 2021 at 4:05 p.m. ET and will host a conference call at 5:00 p.m. ET that day.

Investors and analysts may participate via phone by calling 1-800-322-9079 from the United States and 1-973-582-2717 from other locations. To ensure timely access, participants should dial in approximately 10 minutes before the call starts. A listen-only webcast will be provided at www.mondelezinternational.com.

A replay of the conference call will be available until April 29, 2021 by calling 1-855-859-2056 from the United States and 1-404-537-3406 from other locations. The access code for both the conference call and its rebroadcast is 7149296. An archive of the webcast will be available on the company’s web site.

The company will be live tweeting the event at www.twitter.com/MDLZ.

About Mondelēz International

Mondelēz International, Inc. (Nasdaq: MDLZ) empowers people to snack right in over 150 countries around the world. With 2020 net revenues of approximately $27 billion, MDLZ is leading the future of snacking with iconic global and local brands such as OREO, belVita and LU biscuits; Cadbury Dairy Milk, Milka and Toblerone chocolate; Sour Patch Kids candy and Trident gum. Mondelēz International is a proud member of the Standard and Poor’s 500, Nasdaq 100 and Dow Jones Sustainability Index. Visit www.mondelezinternational.com or follow the company on Twitter at www.twitter.com/MDLZ.

Contact: Jess Vogl (Media) Shep Dunlap (Investors)  
  +1 847 943 5678 +1 847 943 5454  
  [email protected] [email protected]

 



Atos SE Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, April 09, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Atos SE (“Atos” or the “Company”) (OTC: AEXAY) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or if to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Atos issued a press release on April 1, 2021, revealing that its auditors issued a “qualified opinion . . . as to two US legal entities representing 11% of 2020 consolidated revenue that require additional diligences.” Specifically, these auditors identified “internal weaknesses over financial reporting process and revenue recognition in accordance with IFRS 15 leading to several accounting errors, as well as risk of override of controls in this respect.” Atos stated that it had hired external firms in order to conduct an investigation and that, the auditors had not been able to obtain sufficient evidence that Atos’ financial statements were free of material misstatements within the necessary timeframe, due to those procedures. On April 1, 2021, Atos’ share price fell $1.67 per share, or 10.81%, on this news to close at $13.78 per share, thereby injuring investors.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising



WillScot Mobile Mini Holdings to Announce First Quarter 2021 Results on April 29, 2021

PHOENIX, April 09, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corporation (Nasdaq: WSC) today announced that it will release its first quarter 2021 financial results on Thursday, April 29, 2021 after the markets close.

Chief Executive Officer, Brad Soultz and Chief Financial Officer, Tim Boswell will host a conference call and webcast on Friday, April 30, 2021 at 10:00 a.m. EDT to discuss the results.

The live call can be accessed by dialing (855) 312-9420 (US/Canada toll-free) or (210) 874-7774 (International). A live webcast will also be accessible via the “Events & Presentations” section of the company’s website www.willscotmobilemini.com. An archived version of the webcast will be available for 60 days following the call.

About WillScot Mobile Mini Holdings

WillScot Mobile Mini Holdings trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative flexible workspace and portable storage solutions. WillScot Mobile Mini services diverse end markets across all sectors of the economy from a network of approximately 275 branch locations and additional drop lots throughout the United States, Canada, Mexico, and the United Kingdom.

Additional Information and Where to Find It

Additional information can be found on the company’s website at www.willscotmobilemini.com 

Contact Information

Investor Inquiries:

Nick Girardi
[email protected]

Media Inquiries:

Scott Junk
[email protected]



ISS Recommends Blucora Stockholders Vote For Boardroom Change on Ancora’s WHITE Proxy Card

ISS Recommends Blucora Stockholders Vote For Boardroom Change on Ancora’s WHITE Proxy Card

Leading Proxy Advisory Firm ISS Concludes Change is Warranted and Supports the Addition of Direct Stockholder Representation on the Blucora Board

ISS Recommends Voting FOR Nominee Fredrick D. DiSanto, While Only Recommending Voting to Re-Elect Six Current, Unopposed Members of the Board

Leading Proxy Advisory Firm Glass Lewis Acknowledges Ancora Raises Legitimate Concerns

Ancora Urges Stockholders to Vote on the WHITE Proxy Card to Elect All Four Members of its Diverse Slate of Financial Services Experts

CLEVELAND–(BUSINESS WIRE)–
Ancora Holdings, Inc. (together with its affiliates, “Ancora”), which collectively with the other participants in its solicitation beneficially owns approximately 3.4% of the outstanding common stock of Blucora, Inc. (NASDAQ: BCOR) (“Blucora” or the “Company”), today announced that Institutional Shareholder Services Inc. (“ISS”) is recommending that stockholders vote for change on the WHITE proxy card. In its report, ISS has endorsed Ancora’s case for boardroom change, recommended for the election of wealth management expert and stockholder representative Fredrick D. DiSanto, and only recommends re-electing six current, unopposed members of the Board of Directors (the “Board”). In addition, Glass, Lewis & Co., LLC (“Glass Lewis”) has released a report that acknowledges Ancora raises legitimate concerns.

As a reminder, Ancora is seeking to elect Mr. DiSanto, Cindy Schulze Flynn, Robert D. MacKinlay and Kimberly Smith Spacek to Blucora’s ten-member Board at the Company’s Annual Meeting of Stockholders on April 21, 2021. Ancora urges Blucora’s stockholders to visit www.ABetterBlucora.com to obtain important information, including instructions for how to vote on the WHITE Proxy Card.

In its report, ISS noted:1

  • “The merits of the issues raised by the dissident lead to a conclusion that change is warranted, specifically in the form of direct shareholder representation in the boardroom.”
  • “Shareholders are therefore recommended to vote on the dissident’s WHITE proxy card for dissident nominee DiSanto […]”
  • “BCOR shareholders will likely benefit from taking steps to 1) ensure that strategic alternatives are appropriately considered and 2) help assess if Walters is the right fit for the CEO position.”
  • “[…] the board may be hard-pressed to harvest crossover benefits if, as indicated in engagement with ISS, it does not anticipate having key performance indicators for inter-segment synergies before the investor day scheduled for June. Longstanding shareholders, in particular, may be disappointed that the board still does not have KPIs for a strategic goal that the company has touted since late 2015.”
  • “If Blucora had successfully integrated its acquired assets and achieved the synergies projected at the time of the transactions, it would have been in a better position to absorb the pandemic impact with either a smaller impairment charge or no charge at all.”
  • “Over the tenure of the CEO, from Jan. 30, 2020 through the unaffected date, BCOR shares returned (27.7) percent, underperforming the peer median by 73.3 percentage points and the S&P 1500 Diversified Financials Index by 47.5 percentage points.”
  • “From the company’s strategy change, signaled publicly by the announcement of its acquisition of HD Vest and divesture of Infospace and Monoprice on Oct. 14, 2015, BCOR shares have returned 11.4 percent, 105.0 percentage points below its peer median and 95.5 percentage points below the index.
  • “[…] the dissident’s claim that the company’s executive pay practices may not be ideally aligned with the interests of shareholders appear valid.”
  • “Although Walters may ultimately prove to have been the right choice as CEO (his ability to effect a turnaround was undoubtedly complicated by the outbreak of a global pandemic only weeks after his appointment), shareholders still lack definitive evidence in that regard.”
  • “Although the board underscores the fact that the dissident is only a 3.4 percent shareholder, Ancora’s stake is nonetheless more than twice that of the board and management combined.”

In its report, Glass Lewis noted:2

  • “[…] our analyses find no compelling case to suggest the Company has been able to generate attractive, durable and competitive shareholder value over substantially any relevant, unaffected time period spanning at least one full year, including during the fullness of Mr. Walters’ tenure as CEO. Even focusing solely on Blucora’s current fight materials seems to invite some confusion around the run-up to the Company’s January 2020 pivot […] we find Blucora’s more recent effort to retroactively illuminate its succession process arguably invites more questions than it answers.
  • “[…] it is worth noting the board’s case seems to rely on a number of shaky tenets. For example, Mr. Walters’, ‘significant knowledge of the tax industry,’ appears to be very heavily predicated on his six-year, pre-CEO tenure on the Blucora board, a period during which, as previously described, the Company deeply underperformed relevant benchmarks; that trend has continued in pointed fashion during his tenure as chief executive.
  • “Placed in historical context, then, many of the current synergistic initiatives seem to hew much closer to syllogistic rebranding than meaningful reinvention. Secondly, and more problematic still, the underpinnings of the synergy opportunity are not spelled out in Blucora’s materials.”
  • “[…] value mostly seems to have accrued to Blucora’s executives, who, with the assistance of poor pay architecture, have collectively reaped significant compensation, despite generating measurably dismal returns and providing investors very little in the way of concrete measurables.”

Mr. DiSanto, Ancora’s Chairman and Chief Executive Officer, commented:

“Ancora is pleased that ISS is recommending stockholders vote on the white card to facilitate sorely-needed change in Blucora’s boardroom. Notably, ISS acknowledges that the incumbent Board has presided over poor financial returns, suspect corporate governance practices and inadequate compensation and strategy decisions. While I appreciate that ISS has recommended my election to the Board, I firmly believe that it would be in the best interests of stockholders and stakeholders for Cindy, Rob and Kim to also be elected. The sum-of-the-parts of our slate is the right solution at the right time for Blucora, especially given the glaring attrition at Avantax and headwinds for TaxAct. Our entire slate looks forward to putting this contest behind us and working in a highly-collaborative manner with the remaining incumbents to deliver the results stockholders have been waiting for since 2015.”

As noted, we believe our nominees are the right change agents at the right moment in time:

  • Mr. DiSanto brings a deep understanding of the wealth management industry’s various client markets, important ownership perspectives and valuable corporate governance insight, including with respect to appropriate incentive compensation for executives.
  • Ms. Flynn has two decades of experience holding c-level roles at publicly-traded financial services companies, whereat she helped wealth management and tax leaders develop and implement strategies for growing their brands and revenue streams. Ms. Flynn has held c-level marketing roles at New York Community Bancorp, Inc. (NYSE: NYCB) and Citizens Financial Group, Inc. (NYSE: CFG).
  • Mr. MacKinlay knows tax services and wealth management extremely well based on his two decades of experience at Cohen & Company, where he was National Managing Partner and drove hundreds of millions of dollars in client assets to SEQUOIA Financial Group. He also advised many public companies while at KPMG.
  • Ms. Spacek has vast experience in the investment management, broker-dealer and broader financial services sectors from her time at Owl Creek Asset Management, Davidson Kempner Capital Management and ABN AMRO Bank. She understands business development, advisor and investor relations, and how to develop effective fee structures.

About Ancora

Ancora Holdings, Inc. is an employee owned, Cleveland, Ohio based holding company which wholly owns four separate and distinct SEC Registered Investment Advisers and a broker dealer. Ancora Advisors LLC specializes in customized portfolio management for individual investors, high net worth investors, investment companies (mutual funds), and institutions such as pension/profit sharing plans, corporations, charitable & “Not-for Profit” organizations, and unions. Ancora Family Wealth Advisors, LLC is a leading, regional investment and wealth advisor managing assets on behalf of families and high net-worth individuals. Ancora Alternatives LLC specializes in pooled investments (hedge funds/investment limited partnerships). Ancora Retirement Plan Advisors, Inc. specializes in providing non-discretionary investment guidance for small and midsize employer sponsored retirement plans. Inverness Securities, LLC is a FINRA registered Broker Dealer.


1 Permission to quote was not sought or granted. Emphasis added.

2 Permission to quote was not sought or granted. Emphasis added.

For Investors:

Ancora Alternatives

James Chadwick

(216) 593-5048

[email protected]

Saratoga Proxy Consulting LLC

John Ferguson / Joe Mills, 212-257-1311

[email protected] / [email protected]

For Media:

Profile

Greg Marose / Charlotte Kiaie, 347-343-2999

[email protected] / [email protected]

KEYWORDS: Ohio United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Noranda Income Fund Supports Mass Vaccination Efforts in Salaberry-de-Valleyfield Region

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) is proud to announce that it has partnered with Glencore Canada, Collège de Valleyfield and the Centre de services scolaire de la Vallée-des-Tisserands to implement and finance a mobile vaccination clinic. This partnership has been formed to support mass vaccination efforts against COVID-19 in the Salaberry-de-Valleyfield, Quebec region where the Fund’s electrolytic zinc processing facility is located. The Fund and its local partners held a virtual press conference earlier today to mark the occasion.

“Since the onset of the pandemic, everyone at the facility has worked tirelessly to ensure the health and safety of our employees, and our people have continued to accomplish remarkable work in challenging circumstances. The opportunity to support mass vaccination efforts is perfectly aligned with our role as a longstanding and engaged member of the local community and I am proud of our team’s leadership in this regard. We also remain committed to maintaining our operational discipline and our strict onsite COVID-19 protocols as vaccination efforts roll out,” said Liana Centomo, Chief Executive Officer of Canadian Electrolytic Zinc Limited (“CEZInc”), the Fund’s Manager.

Once in place, the mobile vaccination clinic will be able to administer nearly 180 vaccine doses daily with vaccination expected to begin in May. The vaccine will be available, free of charge, to all CEZinc employees, their immediate families and the community at large.


Noranda Income Fund

is an income trust whose units trade on the Toronto Stock Exchange under the symbol “NIF.UN”. Noranda Income Fund owns the electrolytic zinc processing facility and ancillary assets (the “Processing Facility”) located in Salaberry-de-Valleyfield, Quebec. The Processing Facility is the second-largest zinc processing facility in North America and the largest zinc processing facility in eastern North America, where the majority of zinc customers are located. It produces refined zinc metal and various by-products from sourced zinc concentrates. The Processing Facility is operated and managed by Canadian Electrolytic Zinc Limited, a wholly-owned subsidiary of Glencore Canada Corporation.

Further information about Noranda Income Fund can be found at:


www.norandaincomefund.com

.

For further information, please contact:

Paul Einarson,
Chief Financial Officer of Canadian Electrolytic Zinc Limited, Noranda Income Fund’s Manager
Tel: 514-745-9380
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4138dbfa-d3c9-4f79-9aa2-4c3c15692474



 

Number of Shares

2.5% of the Fund’s outstanding shares as of March 31, 2021

Commencement Date

April 16, 2021

Expiration Date and Time

May 14, 2021 at 5:00 p.m. Eastern Time, unless otherwise extended

Price

Net asset value per share determined as of March 31, 2021

The terms and conditions of the Tender Offer will be set forth in the Fund’s Offer to Purchase, the related Letter of Transmittal and other related documents. As soon as the Tender Offer commences, the Fund will file with the Securities and Exchange Commission (the “SEC”) a tender offer statement on Schedule TO and related exhibits, including an Offer to Purchase, a related Letter of Transmittal and other related documents (the “Offer Documents”).

This announcement is for informational purposes only and is not a recommendation, an offer to purchase or a solicitation of an offer to sell shares of the Fund. The Offer Documents will be distributed to Fund shareholders. Shareholders may obtain additional copies of the Offer Documents, when available, without charge, by contacting Georgeson LLC, the Fund’s Tender Offer information agent, toll free at (877) 278-9670. Shareholders can also obtain the Offer Documents, when filed, free of charge on the SEC’s website at www.sec.gov. Shareholders should read these documents and related exhibits carefully as the documents contain important information about the Fund’s Tender Offer.

If you have questions about the Tender Offer and hold the Fund’s shares through a broker or other nominee holder, you can call your broker or other nominee holder directly. You may also call Georgeson LLC, the Fund’s Tender Offer information agent, toll free at (877) 278-9670, with any questions.

The Tender Offer will not be made to, nor will tenders pursuant to the Tender Offer be accepted from or on behalf of, shareholders in any jurisdiction in which making or accepting the Tender Offer would violate that jurisdiction’s laws.

BNY Mellon Investment Adviser, Inc., the investment adviser for the Fund, is part of BNY Mellon Investment Management. BNY Mellon Investment Management is one of the world’s leading investment management organizations and one of the top U.S. wealth managers, with US $2.2 trillion in assets under management as of December 31, 2020. BNY Mellon Investment Management encompasses BNY Mellon’s affiliated investment management firms, wealth management organization and global distribution companies. Through an investor-first approach, BNY Mellon Investment Management brings to clients the best of both worlds: specialist expertise from eight world-class investment firms offering solutions across every major asset class, backed by the strength, stability, and global presence of The Bank of New York Mellon Corporation (NYSE: BK), one of the world’s most trusted investment partners, which has US $41.1 trillion in assets under custody and/or administration as of December 31, 2020.

BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may also be used as a generic term to reference the Corporation as a whole or its various subsidiaries generally. Additional information on BNY Mellon Investment Management is available on www.im.bnymellon.com. BNY Mellon Investment Management’s website is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate the website in this release.

The Fund’s investment returns and principal values will fluctuate so that an investor’s shares may be worth more or less than the original cost. There is no assurance that the Fund will achieve its investment objective.

For Press Inquiries:

BNY Mellon Investment Adviser, Inc.

Benjamin Tanner

(212) 635-8676

For Other Inquiries:

BNY Mellon Securities Corporation

The National Marketing Desk

240 Greenwich Street

New York, New York 10286

1-800-334-6899

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Portnoy Law: Lawsuit Filed on Behalf of Ebang International Holdings, Inc. Investors

Click

here

to join the case

LOS ANGELES, April 09, 2021 (GLOBE NEWSWIRE) —

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Ebang International Holdings, Inc. (“Ebang” or “the Company”) (NASDAQ: EBON) investors that acquired securities between June 26, 2020 and April 5, 2021.

Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.

Analyst Hindenburg Research published a report on April 6, 2021, alleging the Chinese cryptocurrency company is directing proceeds from its IPO last year into a “series of opaque deals with insiders and questionable counterparties. “Ebang raised $21 million in November 2020, According to the report, stating that the proceeds would go “primarily for development,” and that $21 million was allegedly directed to repay related-party loans to a relative of the company’s Chairman/CEO Dong Hu. It was also noted in this report that Ebang’s earlier efforts to go public on the Hong Kong Stock Exchange failed as a result, to widespread media coverage of its relationship with Yindou, a Chinese peer-to-peer online lending scheme that defrauded 20,000 retail investors in 2018, with $655 million “vanish(ing) into thin air”. On April 6, 2021, share price fell $0.82, or approximately 13%, on this news, to close at $5.53 per share thereby injuring investors.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising



The National Security Group, Inc. Declares Cash Dividend

The National Security Group, Inc. Declares Cash Dividend

ELBA, Ala.–(BUSINESS WIRE)–
On April 9, 2021, the Board of Directors of The National Security Group, Inc. (NASDAQ:NSEC), declared a quarterly dividend of $0.06 per share. This cash dividend is payable on May 28, 2021, to shareholders of record May 3, 2021.

About The National Security Group, Inc.

The National Security Group, Inc. (NASDAQ Symbol: NSEC), through its property and casualty and life insurance subsidiaries, offers property, casualty, life, accident and health insurance in ten states. The Company primarily writes personal lines property coverage including specialty market dwelling fire and windstorm, homeowners and mobile homeowners lines of insurance. The Company also offers life, accident and health, supplemental hospital and cancer insurance products. The Company was founded in 1947 and is based in Elba, Alabama. Additional information about the Company, including additional details of recent financial results, can be found on our website: www.nationalsecuritygroup.com.

Brian McLeod

Chief Financial Officer

(334) 897-2273

KEYWORDS: United States North America Alabama

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo

Healixa Inc. Provides Pharmacy Business Progress Updates

Emerald Organic Products Inc. (d/b/a Healixa Inc.) in Final Stages of Testing for its Proprietary Prescription Delivery Technology

HOLBROOK, New York, April 09, 2021 (GLOBE NEWSWIRE) — Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the “Company”, “EMOR”, “Healixa”), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, is pleased to provide a progress update on the Company’s pharmacy business plan rollout subsequent to its recent acquisition of 5 Star Pharmacy LLC in Allen, Texas.

“The upcoming launch of the Company’s digital pharmacy application alongside our active acquisition strategy should fuel significant growth,” commented Ian Parker, CEO of Healixa. “We are pleased to provide an update on the previously announced pharmacy business plan rollout, as well as highlight some of the Company’s recent initiatives.”


Pharmacy Business Plan Rollout
 

  • The Company has begun integrating 5 Star Pharmacy LLC into its digital healthcare ecosystem;
  • The Company is in its final stages of testing its Rx last mile logistics application;
  • Upon completion of testing this quarter the Company’s digital pharmacy application will be launched nationally in strategic regional locations in and in phases, beginning with select metropolitan areas.  


Advisory Board Build-Out

Following the Company’s February 24, 2021 announcement regarding its name change to Healixa and refined corporate vision for the future, there have been multiple noteworthy appointments to the Company’s Advisory Board: 

The Company has also bolstered its team with the recent appointment Kealy Altman as Vice President of Marketing. 

“The Company is undergoing a massive transformation to become a formidable force in the healthtech space,” added Parker. “I look forward to providing additional updates to shareholders in the near future as we begin commercializing our  Rx  last mile logistics application.”

About Emerald Organic Products Inc.

Emerald Organic Products Inc. has recently changed its name to Healixa Inc. in the State of Nevada and continues to trade under the symbol OTC: EMOR. Filings have been made to reflect the name change on the OTC ticker board.  

About Healixa Inc.

Healixa is a technology company with assets in both healthtech and fintech.  Healixa marries code and care to create exceptional experiences in healthtech.  The Company’s people-first approach is designed to humanize care via purpose-driven ethical engineering practices, deploying simple solutions for complex global challenges.

Healixa offers value-based tech solutions to enterprise partner channels across a broad range of industries including employer benefits, travel, pharma, logistics and more.

Forward-looking Statements

Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa Inc., f.k.a. Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. 



Kirin M. Smith
PCG Advisory, Inc.
1-646-823-8656
[email protected]

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

PR Newswire

LOS ANGELES, April 9, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of FibroGen, Inc. (“FibroGen” or “the Company”) (NASDAQ: FGEN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. FibroGen issued a statement on April 6, 2021, providing “clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from the roxadustat Phase 3 program for the treatment of anemia of chronic kidney disease (‘CKD’).” The Company stated that its safety analysis “included post-hoc changes to the stratification factors.” FibroGen disclosed that based on analyses using the pre-specified stratification factors, the Company “cannot conclude that roxadustat reduces the risk of (or is superior to) MACE+ in dialysis, and MACE and MACE+ in incident dialysis compared to epoetin-alfa.” Based on this news, shares of FibroGen dropped sharply.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
[email protected] 
www.schallfirm.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ongoing-investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-fibrogen-inc-and-encourages-investors-with-losses-of-100-000-to-contact-the-firm-301265951.html

SOURCE The Schall Law Firm